Zobrazeno 1 - 10
of 290
pro vyhledávání: '"William H. Shrank"'
Autor:
Lynn M. Neilson, Elizabeth C. S. Swart, Chester B. Good, William H. Shrank, Rochelle Henderson, Chronis Manolis, Natasha Parekh
Publikováno v:
Cardiology and Therapy, Vol 8, Iss 1, Pp 135-143 (2019)
Abstract Introduction Value-based contracts (VBCs) that link drug payments to disease-related performance metrics aim to increase the value and lower the cost of medications by aligning incentives and sharing risk between payers and pharmaceutical ma
Externí odkaz:
https://doaj.org/article/d3e3fe18de9140028597fda30256ad01
Autor:
Benjamin L. Howell PhD, Partha Deb PhD, Sai Ma PhD, Rachel O. Reid MD, Jesse Levy PhD, Gerald F. Riley MSPH, Patrick H. Conway MD, William H. Shrank MD
Publikováno v:
MDM Policy & Practice, Vol 2 (2017)
There are considerable quality differences across private Medicare Advantage insurance plans, so it is important that beneficiaries make informed choices. During open enrollment for the 2013 coverage year, the Centers for Medicare & Medicaid Services
Externí odkaz:
https://doaj.org/article/36709eb6a75e4994aa28bf1439fa1d87
Publikováno v:
Health affairs (Project Hope). 41(9)
Value-based payment programs adjust payments to providers based on spending, quality, or health outcomes. Concern that these programs penalize providers disproportionately serving vulnerable patients prompted calls to adjust performance measures for
Publikováno v:
Health Affairs. 41:1307-1315
Autor:
Charron L. Long, Stephanie M. Franklin, Angela S. Hagan, Yong Li, Jeremiah S. Rastegar, Bill Glasheen, William H. Shrank, Brian W. Powers
Publikováno v:
Health Affairs. 41:557-562
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:379-386
Medication nonadherence in the United States contributes to 125,000 deaths and 10% of hospitalizations annually. The pain of preventable deaths and the personal costs of nonadherence are borne disproportionately by Black, Latino, and other minority g
Publikováno v:
JAMA health forum. 1(9)
Publikováno v:
JAMA health forum. 2(4)
Publikováno v:
Journal of General Internal Medicine. 37:2559-2561
Autor:
Walid F. Gellad, Chester B. Good, William H. Shrank, Alvaro San-Juan-Rodriguez, Inmaculada Hernandez
Publikováno v:
J Manag Care Spec Pharm
BACKGROUND: Medicare Part B pharmaceutical spending has increased rapidly, more than doubling in 2006-2017. Yet, it is unclear whether this increase was driven by increased utilization or increased cost per claim. OBJECTIVE: To evaluate the relative